[ad_1]
MADE IN CHINA The Beijing Institute of Biologicals states that the Sinopharm vaccine is 79 percent effective. —REUTERS
MANILA, Philippines – Chinese state-owned company Sinopharm has applied for emergency use authorization (USA) for its Covid-19 vaccine in the Philippines, the Food and Drug Administration (FDA) confirmed on Tuesday.
FDA CEO Eric Domingo said they are in the process of reviewing the Sinopharm documents.
“An application was submitted online yesterday afternoon and the FDA is verifying the content of the submission now,” Domingo told INQUIRER.net in a text message.
It was presidential spokesman Harry Roque who announced Sinopharm’s application for a USA, but the FDA could not immediately confirm it.
Roque has said that the Sinopharm vaccine is the preferred one by President Rodrigo Duterte. He was also endorsed by Duterte’s special envoy to China, Ramon Tulfo, who recently admitted receiving vaccine jobs in October, along with other anonymous cabinet officials.
So far, the FDA has granted an EUA to only three vaccines developed by Pfizer-BioNTech, AstraZeneca, and Sinovac.
Meanwhile, India’s Bharat Biotech USA application and Russia’s Gamaleya Research Institute remain under evaluation.
EDV
Read next
Subscribe to INQUIRER PLUS to get access to The Philippine Daily Inquirer and more than 70 other titles, share up to 5 gadgets, listen to the news, download from 4am and share articles on social media. Call 896 6000.
For comments, complaints or inquiries, please contact us.
[ad_2]
